QA Investigation Results

Pennsylvania Department of Health
SOUTH PHILADELPHIA DIALYSIS CENTER
Health Inspection Results
SOUTH PHILADELPHIA DIALYSIS CENTER
Health Inspection Results For:


There are  18 surveys for this facility. Please select a date to view the survey results.

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.



Initial Comments:

Based on the findings of an onsite unannounced Medicare recertification survey conducted on January 22, 2024 through January 24, 2024, South Philadelpia Dialysis Center was was identified to have the following standard level deficiency that was determined to be in substantial compliance with the following requirements of 42 CFRrequirements of 42 CFR, Part 494.62, Subpart B, Conditions for Coverage of Suppliers of End-Stage Renal Disease (ESRD) Services-Emergency Preparedness.



Plan of Correction:




494.62(d)(2) STANDARD
EP Testing Requirements

Name - Component - 00
§416.54(d)(2), §418.113(d)(2), §441.184(d)(2), §460.84(d)(2), §482.15(d)(2), §483.73(d)(2), §483.475(d)(2), §484.102(d)(2), §485.68(d)(2), §485.542(d)(2), §485.625(d)(2), §485.727(d)(2), §485.920(d)(2), §491.12(d)(2), §494.62(d)(2).

*[For ASCs at §416.54, CORFs at §485.68, REHs at §485.542, OPO, "Organizations" under §485.727, CMHCs at §485.920, RHCs/FQHCs at §491.12, and ESRD Facilities at §494.62]:

(2) Testing. The [facility] must conduct exercises to test the emergency plan annually. The [facility] must do all of the following:

(i) Participate in a full-scale exercise that is community-based every 2 years; or
(A) When a community-based exercise is not accessible, conduct a facility-based functional exercise every 2 years; or
(B) If the [facility] experiences an actual natural or man-made emergency that requires activation of the emergency plan, the [facility] is exempt from engaging in its next required community-based or individual, facility-based functional exercise following the onset of the actual event.
(ii) Conduct an additional exercise at least every 2 years, opposite the year the full-scale or functional exercise under paragraph (d)(2)(i) of this section is conducted, that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or individual, facility-based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop that is led by a facilitator and includes a group discussion using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(iii) Analyze the [facility's] response to and maintain documentation of all drills, tabletop exercises, and emergency events, and revise the [facility's] emergency plan, as needed.

*[For Hospices at 418.113(d):]
(2) Testing for hospices that provide care in the patient's home. The hospice must conduct exercises to test the emergency plan at least annually. The hospice must do the following:
(i) Participate in a full-scale exercise that is community based every 2 years; or
(A) When a community based exercise is not accessible, conduct an individual facility based functional exercise every 2 years; or
(B) If the hospice experiences a natural or man-made emergency that requires activation of the emergency plan, the hospital is exempt from engaging in its next required full scale community-based exercise or individual facility-based functional exercise following the onset of the emergency event.
(ii) Conduct an additional exercise every 2 years, opposite the year the full-scale or functional exercise under paragraph (d)(2)(i) of this section is conducted, that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or a facility based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop that is led by a facilitator and includes a group discussion using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.

(3) Testing for hospices that provide inpatient care directly. The hospice must conduct exercises to test the emergency plan twice per year. The hospice must do the following:
(i) Participate in an annual full-scale exercise that is community-based; or
(A) When a community-based exercise is not accessible, conduct an annual individual facility-based functional exercise; or
(B) If the hospice experiences a natural or man-made emergency that requires activation of the emergency plan, the hospice is exempt from engaging in its next required full-scale community based or facility-based functional exercise following the onset of the emergency event.
(ii) Conduct an additional annual exercise that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or a facility based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop led by a facilitator that includes a group discussion using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(iii) Analyze the hospice's response to and maintain documentation of all drills, tabletop exercises, and emergency events and revise the hospice's emergency plan, as needed.


*[For PRFTs at §441.184(d), Hospitals at §482.15(d), CAHs at §485.625(d):]
(2) Testing. The [PRTF, Hospital, CAH] must conduct exercises to test the emergency plan twice per year. The [PRTF, Hospital, CAH] must do the following:
(i) Participate in an annual full-scale exercise that is community-based; or
(A) When a community-based exercise is not accessible, conduct an annual individual, facility-based functional exercise; or
(B) If the [PRTF, Hospital, CAH] experiences an actual natural or man-made emergency that requires activation of the emergency plan, the [facility] is exempt from engaging in its next required full-scale community based or individual, facility-based functional exercise following the onset of the emergency event.
(ii) Conduct an [additional] annual exercise or and that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or individual, a facility-based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop that is led by a facilitator and includes a group discussion, using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(iii) Analyze the [facility's] response to and maintain documentation of all drills, tabletop exercises, and emergency events and revise the [facility's] emergency plan, as needed.

*[For PACE at §460.84(d):]
(2) Testing. The PACE organization must conduct exercises to test the emergency plan at least annually. The PACE organization must do the following:
(i) Participate in an annual full-scale exercise that is community-based; or
(A) When a community-based exercise is not accessible, conduct an annual individual, facility-based functional exercise; or
(B) If the PACE experiences an actual natural or man-made emergency that requires activation of the emergency plan, the PACE is exempt from engaging in its next required full-scale community based or individual, facility-based functional exercise following the onset of the emergency event.
(ii) Conduct an additional exercise every 2 years opposite the year the full-scale or functional exercise under paragraph (d)(2)(i) of this section is conducted that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or individual, a facility based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop that is led by a facilitator and includes a group discussion, using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(iii) Analyze the PACE's response to and maintain documentation of all drills, tabletop exercises, and emergency events and revise the PACE's emergency plan, as needed.

*[For LTC Facilities at §483.73(d):]
(2) The [LTC facility] must conduct exercises to test the emergency plan at least twice per year, including unannounced staff drills using the emergency procedures. The [LTC facility, ICF/IID] must do the following:
(i) Participate in an annual full-scale exercise that is community-based; or
(A) When a community-based exercise is not accessible, conduct an annual individual, facility-based functional exercise.
(B) If the [LTC facility] facility experiences an actual natural or man-made emergency that requires activation of the emergency plan, the LTC facility is exempt from engaging its next required a full-scale community-based or individual, facility-based functional exercise following the onset of the emergency event.
(ii) Conduct an additional annual exercise that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or an individual, facility based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop that is led by a facilitator includes a group discussion, using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(iii) Analyze the [LTC facility] facility's response to and maintain documentation of all drills, tabletop exercises, and emergency events, and revise the [LTC facility] facility's emergency plan, as needed.

*[For ICF/IIDs at §483.475(d)]:
(2) Testing. The ICF/IID must conduct exercises to test the emergency plan at least twice per year. The ICF/IID must do the following:
(i) Participate in an annual full-scale exercise that is community-based; or
(A) When a community-based exercise is not accessible, conduct an annual individual, facility-based functional exercise; or.
(B) If the ICF/IID experiences an actual natural or man-made emergency that requires activation of the emergency plan, the ICF/IID is exempt from engaging in its next required full-scale community-based or individual, facility-based functional exercise following the onset of the emergency event.
(ii) Conduct an additional annual exercise that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or an individual, facility-based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop that is led by a facilitator and includes a group discussion, using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(iii) Analyze the ICF/IID's response to and maintain documentation of all drills, tabletop exercises, and emergency events, and revise the ICF/IID's emergency plan, as needed.

*[For HHAs at §484.102]
(d)(2) Testing. The HHA must conduct exercises to test the emergency plan at
least annually. The HHA must do the following:
(i) Participate in a full-scale exercise that is community-based; or
(A) When a community-based exercise is not accessible, conduct an annual individual, facility-based functional exercise every 2 years; or.
(B) If the HHA experiences an actual natural or man-made emergency that requires activation of the emergency plan, the HHA is exempt from engaging in its next required full-scale community-based or individual, facility based functional exercise following the onset of the emergency event.
(ii) Conduct an additional exercise every 2 years, opposite the year the full-scale or functional exercise under paragraph (d)(2)(i) of this section is conducted, that may include, but is not limited to the following:
(A) A second full-scale exercise that is community-based or an individual, facility-based functional exercise; or
(B) A mock disaster drill; or
(C) A tabletop exercise or workshop that is led by a facilitator and includes a group discussion, using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(iii) Analyze the HHA's response to and maintain documentation of all drills, tabletop exercises, and emergency events, and revise the HHA's emergency plan, as needed.

*[For OPOs at §486.360]
(d)(2) Testing. The OPO must conduct exercises to test the emergency plan. The OPO must do the following:
(i) Conduct a paper-based, tabletop exercise or workshop at least annually. A tabletop exercise is led by a facilitator and includes a group discussion, using a narrated, clinically relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan. If the OPO experiences an actual natural or man-made emergency that requires activation of the emergency plan, the OPO is exempt from engaging in its next required testing exercise following the onset of the emergency event.
(ii) Analyze the OPO's response to and maintain documentation of all tabletop exercises, and emergency events, and revise the [RNHCI's and OPO's] emergency plan, as needed.

*[ RNCHIs at §403.748]:
(d)(2) Testing. The RNHCI must conduct exercises to test the emergency plan. The RNHCI must do the following:
(i) Conduct a paper-based, tabletop exercise at least annually. A tabletop exercise is a group discussion led by a facilitator, using a narrated, clinically-relevant emergency scenario, and a set of problem statements, directed messages, or prepared questions designed to challenge an emergency plan.
(ii) Analyze the RNHCI's response to and maintain documentation of all tabletop exercises, and emergency events, and revise the RNHCI's emergency plan, as needed.

Observations:



Based on a review of the facility emergency preparedness program, facility policy, and an interview with the facility administrator and regional director, the facility failed to conduct exercises to test the emergency plan at least annually.

Findings include:

A review of "Facility Emergency Management Plan [EMP] (ICHD, Home)" on January 24, 2024, at approximately 11:00 am states, "Emergency Drills: 2. EMP training exercises: e. Frequency: i. The facility will conduct and/or participate in one (1) exercise to test the facility EMP at least annually..."

A review of the facility emergency preparedness program was conducted on January 24, 2024 at approximately 9:30 am, revealed no documentation of emergency plan training exercises for 2022.

An interview with the facility administrator and regional director confirmed that there was no documentation of emergency plan exercises for 2022.

















Plan of Correction:

The Facility Administrator or designee will hold mandatory in-services for all clinical teammates starting on 02/05/24. Surveyor observations will be reviewed. Education will include but not be limited to a review of Policy 4-07-01 "Emergency Management Plan (EMP)" with emphasis on but not limited to: 1) The facility will conduct and/or participate in one (1) exercise to test the facility EMP at least annually, conducted on opposite years (one year full-scale, next year facility-based / exercise of choice). Verification of attendance at in-service will be evidenced by teammate's signatures on in-service sheet.
On 1/31/24, the Facility Administrator in partnership with the Clinical Coordinator scheduled all remaining quarterly and annual EMP drills for the next two years in the facility calendar.
The Facility Administrator or designee will own the scheduling, selection and administration of all annual emergency drills. Documentation including event activated, plans and policies activated, evaluation of plan, required plan revisions and Governing Body review will be maintained in facility's Emergency Management Plan and reviewed quarterly.
The Facility Administrator or designee will review the results of the emergency preparedness drill with teammates during homeroom meetings and with Medical Director during monthly Quality Assessment and Performance Improvement meetings, with supporting documentation included in the meeting minutes. The Facility Administrator is responsible for compliance with this plan of correction.



Initial Comments:

Based on the findings of an onsite unannounced Medicare recertification survey conducted on January 22, 2024 through January 24, 24, 2024, South Philadelphia Dialysis Center, was identified to have the following standard level deficiencies that were determined to be in substantial compliance with the following requirements of 42 CFR, Part 494, Subparts A, B, C, and D, Conditions for Coverage of Suppliers of End-Stage Renal Disease (ESRD) Services.





Plan of Correction:




494.30(a)(1) STANDARD
IC-WEAR GLOVES/HAND HYGIENE

Name - Component - 00
Wear disposable gloves when caring for the patient or touching the patient's equipment at the dialysis station. Staff must remove gloves and wash hands between each patient or station.




Observations:


Based on observation of the clinical area, facility policy and an interview with the facility administrator, the facility did not follow its policy with regard to teammate fingernails. (Observations #2, 4, and 6).

Findings include:

Policy "Infection Control For Dialysis Facilities" was reviewed on January 24, 2023 at approximately 11:30 am. Policy states: "Hand Hygeine: 4. It is a requirement for all DaVita teammates whose primary location is working in a facility have only natural nails and fingernail length should not extend more than 1/4 inch. Traditional nail polish that is not chipped may be worn..."

Observation of the clinical area was conducted on January 22, 2024 from approximately 9:30 am to 11:45 am.

Observation #2. PCT #6 was noted to have artificial fingernails.

Observation #4. RN #2 was noted to have artificial fingernails.

Observation #6. PCT #2 was noted to have artificial fingernails.

An interview with the facility administrator and regional director on January 24, 2024 at approximately 11:00 am confirmed the above findings.












Plan of Correction:

The Facility Administrator or designee will hold mandatory in-services for all clinical teammates starting on 02/05/24. Surveyor observations will be reviewed. Education will include but not be limited to a review of Policy 1-05-01 "Infection Control for Dialysis Facilities" with the emphasis on but not limited to: 1) It is a requirement for all DaVita teammates whose primary location is working in a facility to have only natural nails and fingernail length should not extend more than ¼ inch. Traditional nail polish that is not chipped may be worn. Verification of attendance at in-service will be evidenced by teammate's signatures on in-service sheet.
On 01/25/24, patient care technicians identified in the survey were coached on the infection control risks of artificial nails and directed to have them removed. All active patient care technicians were coached on the DaVita's policy regarding nail hygiene.
The Facility Administrator or designee will conduct infection control audits to verify teammates comply with the nail requirement: weekly for four (4) weeks then ongoing monitoring during monthly infection control audits. Instances of non-compliance will be addressed immediately.
The Facility Administrator or designee will review the audit results with teammates during homeroom meetings, and with Medical Director during monthly Quality Assessment and Performance Improvement meetings. The Facility Administrator will report progress, as well as any barriers to maintaining compliance. Action plans will be evaluated for effectiveness and new plans developed when needed, until sustained compliance is achieved. Supporting documentation will be included in the meeting minutes. The Facility Administrator is responsible for compliance with this plan of correction.



494.30(a)(4)(ii) STANDARD
IC-DISINFECT SURFACES/EQUIP/WRITTEN PROTOCOL

Name - Component - 00
[The facility must demonstrate that it follows standard infection control precautions by implementing-
(4) And maintaining procedures, in accordance with applicable State and local laws and accepted public health procedures, for the-]
(ii) Cleaning and disinfection of contaminated surfaces, medical devices, and equipment.



Observations:



Based on observation, review of policy and procedures, and an interview with the Facility Administrator, it was determined, the facility failed to ensure infection control procedures were followed for machine disinfection by cleaning and disinfecting the Hansen connectors and the counter surface behind the dialysis chair for three (3) of twenty (20) hemodialysis machines observed. (Dialysis machines at station #2, 5 and 7).

Findings include:

A review of policy number 1-05-01 titled, "Infection Control for Dialysis Facilities " was conducted on January 24, 2024 at approximately 11:00 am states, "Purpose: To minimize the spread of infections or bloodborne pathogens in the dialysis facility environment...Disinfection: 13. At the end of each treatment, the dialysis station will be cleaned and disinfected. a. Surfaces to disinfect include but are no limited to: all surfaces in contact with the patient or their belongings (e.g., dialysis chair, tray tables, blood pressure cuffs) and frequently contacted by healthcare personnel (e.g., control panel; top, front, and sides of dialysis machine; touchscreens; countertops)..."

Observation of the clinical area was conducted on January 22, 2024 from approximately 9:30 am through 11:45 am.

Obervations #4. At approximately 10:15 am, it was observed that RN #2, did not disinfect the Hansen connectors of the dialysis machine and did not disinfect the counter surface behind the dialysis chair at Station #7, prior to the start of the next dialysis treatment.

Observation #6. At approximately 10:30 am, it was observed that PCT #2, did not disinfect the Hansen connectors of the dialysis machine and did not disinfect the counter surface behind the dialysis chair at Station #5, prior to the start of the next dialysis treatment.

Observation #10. At approximately 10:50 am, it was observed that PCT #1, did not disinfect the Hansen connectors of the dialysis machine and did not disinfect the counter surface behind the dialysis chair at Station #2, prior to the start of the next dialysis treatment.

An interview with the facility administrator and regional director was conducted on January 24, 2024 at approximately 11:00 am confirmed the above findings.


















Plan of Correction:

The Facility Administrator or designee will hold mandatory in-services for all clinical teammates starting on 02/05/24. Surveyor observations will be reviewed. Education will include but not be limited to a review of Policy 1-05-01 "Infection Control for Dialysis Facilities" with emphasis on but not limited to: 1) Cleaning and/or disinfection of equipment and work surfaces will be performed as soon as possible following exposure to blood or other potentially infectious materials. 2) Use an appropriate disinfectant such as 1:100 (one to one hundred) bleach solution for routine disinfection of environmental surfaces. 3) Surfaces to disinfect include but are not necessarily limited to: all surfaces in contact with the patient or their belongings (e.g., dialysis chair, tray tables, blood pressure cuffs) and frequently contacted by healthcare personnel (e.g., control panel; top, front and sides of dialysis machine; touchscreens; countertops). Verification of attendance at in-service will be evidenced by teammate's signature on the in-service sheet.
Facility Administrator or designee will place emphasis on cleaning the Hansen connectors attached to the delivery system and all areas accessible to patients including the chaise wall behind the dialysis chair. The Facility Administrator or designee will conduct infection control audits to verify machine disinfection and station cleaning comply with infection control policy: daily for two (2) weeks, then weekly for two (2) weeks, then ongoing monitoring with the monthly infection control audit. Instances of non-compliance will be addressed immediately.
The Facility Administrator or designee will review the audit results with teammates during homeroom meetings, and with Medical Director during monthly Quality Assessment and Performance Improvement meetings. The Facility Administrator will report progress, as well as any barriers to maintaining compliance. Action plans will be evaluated for effectiveness and new plans developed when needed, until sustained compliance is achieved. Supporting documentation will be included in the meeting minutes. The Facility Administrator is responsible for compliance with this plan of correction.



494.30(b)(1) STANDARD
IC-O-SIGHT-MONITOR ACTIVITY/IMPLEMENT P&P

Name - Component - 00
The facility must-
(1) Monitor and implement biohazard and infection control policies and activities within the dialysis unit;



Observations:


Based on observation of the sterile supply storage area, facility policy, and an interview with the facility administrator and regional director, the facility did not follow its policy to ensure sterile supples are taken out of circulation by the expiration date for four (4) observations (Observations #14, 15, 16, and 17).

Findings include:

A review of policy number 1-05-01 titled, "Infection Control for Dialysis Facilities " was conducted on January 24, 2024 at approximately 11:00 am states, "Purpose: To minimize the spread of infections or bloodborne pathogens in the dialysis facility environment...Supplies 8. Supplies will be stored in a manner that maintains their integrity...b. Expiration date and package integrity will be verified prior to use..."

Observation of the sterile supply storage area was conducted on January 22, 2024 from approximately 11:30 am to 11:45 am.

Observation #14. Ninety-seven (97) Monoject filter needles size 20 gauge by 1.5 inch were found with an expiration date of 3/15/2022.

Observation #15. Twenty (20) BD microtainer contact activated lancets size 30 gauge by 1.5 millimeter were found with an expiration date of 5/2022.

Observation #16. Seventy-one (71) BD 22 gauge by 1 inch needles were found with an expiration date of 1/31/2023.

Observation #17. Thirty-four (34) VioNex single use antiseptic towelettes were found with an expiration date of 1/1/2023.

An interview with the facility administrator and regional director was conducted on January 24, 2024 at approximately 11:00 am confirmed the above findings.













Plan of Correction:

The Facility Administrator or designee will hold mandatory in-services for all clinical teammates starting on 02/05/24. Surveyor observations will be reviewed. Education will include but not be limited to a review of Policy 1-05-01 "Infection Control for Dialysis Facilities" with the emphasis on but not limited to: 1) Supplies will be stored in a manner that maintains their integrity. 2) Expiration date and package integrity will be verified prior to use. Verification of attendance at in-service will be evidenced by teammates signatures on in-service sheet.
Facility Administrator or designee will emphasize the practice of: 1) regular auditing of housed supplies to check for expired items as part of a monthly process to minimalize the spread of infections or bloodborne pathogens; 2) rotation of new supplies to be placed behind existing supplies when stocking to decrease the risk of supplies expiring prior to use.
On 01/22/24, expired supplies found in the lab room cabinet were immediately and appropriately discarded and the lab room was further audited for any remaining misplaced supplies. Supply room and treatment floor were fully audited 01/29/24 for any remaining expired supplies.
The Facility Administrator or designee will conduct observational audits for expired supplies weekly for four (4) weeks with expected compliance of ninety eight percent (98%), then ongoing compliance will be monitored with monthly infection control audits. Instances of non-compliance will be addressed immediately.
The Facility Administrator or designee will review the audit results with teammates during homeroom meetings, and with Medical Director during monthly Quality Assessment and Performance Improvement meetings. The Facility Administrator will report progress, as well as any barriers to maintaining compliance. Action plans will be evaluated for effectiveness and new plans developed when needed, until sustained compliance is achieved. Supporting documentation will be included in the meeting minutes. The Facility Administrator is responsible for compliance with this plan of correction.



494.90(a)(1) STANDARD
POC-ACHIEVE ADEQUATE CLEARANCE

Name - Component - 00
Achieve and sustain the prescribed dose of dialysis to meet a hemodialysis Kt/V of at least 1.2 and a peritoneal dialysis weekly Kt/V of at least 1.7 or meet an alternative equivalent professionally-accepted clinical practice standard for adequacy of dialysis.


Observations:


Based on review of facility policies/procedure, medical records (MR), and an interview with the facility administrator and regional director, the facility failed to ensure the blood flow rate (BFR) and/or the dialysate flow rate (DFR) was administered per physician order for three (3) of seven (7) incenter hemodialysis patient MR's reviewed. (MR #1, 4, and 5); and the facility failed to provide documentation that a patient requested early treatment termination for three (3) of seven (7) incenter hemodialysis patient MR's reviewed, (MR #1, 3, and 6).


Findings include:

A review of facility policy titled "Pre-Intra-Post Treatment Data Collection, Monitoring and Nursing Assessment" on January 24, 2024 at approximately 11:25 am states, "Policy: 3. Patient identity, prescription and machine settings are verified by teammate prior to initiation of treatment with the exception of blood flow rate which is verified and documented when the ordered rate is obtained after onset of treatment...Prescription components include but are not necessarily limited to: f. Blood flow rate (BFR) g. Dialysate flow rate (DFR)...Intradialytic Data Collection/ Assessment: 10. If the dialysis prescription is not being met (including DFR or change to/inability to obtain prescribed BFR, the reason will be documented and the licensed nurse informed..."

A review of facility policy titled "Prescribed Treatment Time Not Met" on January 24, 2024 at approximately 11:20 am states, "Policy: A. Completion of the Early Termination of Treatment Against Medical Advice Form: 1. The RN will verify that a patient signs the Early Termination of Treatment Against Medical Advice form any time the patient requests to terminate their treatment earlier than the prescribed run time...3. The RN will obtain the patient's signature on the Early Termination of Treatment Against Medical Advice form prior to the patient being rinsed back from their treatment. If unable to obtain the patient's signature prior to rinse-back, the RN will obtain the patient's signature on the form prior to the patient's departure from the facility. 4. A RN must countersign all Early Termination of Treatment Against Medical Advice forms. A witness signature is required only if the patient refuses to sign the form. 5. If a patient refuses to sign the Early Termination of Treatment Against Medical Advice form, the RN will document the patient's refusal with the words "patient refused" in the patient signature box along with the date. Under such circumstances, the RN will sign the form and will also obtain a witness' signature on the form... B. Prescribed Treatment Time Not Met: 1. If shortened/early termination of treatment time exceeds 30 or more minutes, the RN will notify the patient's attending nephrologist to discuss the appropriate intervention (if any), including what additional medical orders may be necessary to address the patient's specific needs...6. The facility's administrator (FA) will verify that all shortened treatments are recorded and trended, and the FA shall verify that such records are reviewed and discussed at the facility health meetings, as appropriate..."

A review of patient medical records (MR) was completed on January 23, 2024 from approximately 11:00 am to 2:30 pm.

MR #1: Admission Date: 12/18/17. Dialysis order date: 1/18/2024. Frequency: Tuesday, Thursday, and Saturday; Target Weight: 75.5 Kg; Dialyzer: Revaclear 300; Dialysate: 3 K, 2.5 CA, 35 HCO3, 138 NA; Treatment Duration: 210 minutes; BFR: 400; DFR: 800 (Prior orders: BFR: 400; DFR: 500).

Review of Dialysis Treatment Details Reports revealed the BFR/DFR was not administered at prescribed rates on the following dates:

1/11/2024, during entire treatment the BFR was administered at 350 ml/hr.

1/13/2024, during entire treatment the BFR was administered at 350 ml/hr.

1/16/2024, from 1:02 pm through 2:32 pm, the BFR as administered at 425 ml/min and the DFR was administered at 800 ml/min.

1/18/2024, from 2:02 pm through 3:03 pm, the DFR was administered at 500 ml/min.

1/20/2024, during entire treatment DFR was administered at 500 ml/min.

There was no documentation in the medical record that the hemodialysis staff had obtained a physician order to allow the BFR/DFR to be administered at a rate different from the prescribed amount for any of the above dates and there was no documentation of a reason why the BFR/DFR was administered at a rate different from the prescribed amount for any of the above dates.

Review of Dialysis Treatment Details Reports revealed the patient requested early termination of treatment on the following date:

1/11/2024. Treatment time 170 minutes, short 40 minutes.

There is no documentation of an Early Termination of Treatment Against Medical Advice form in the MR for the above date.

MR # 3: Admission Date: 9/8/2023. Dialysis order date: 1/9/2024. Frequency: Monday, Wednesday, and Saturday; Target Weight: 72.5 Kg; Dialyzer: Revaclear 300; Dialysate: 1 K, 2.5 CA, 35 HCO3, 136 NA; Treatment Duration: 210 minutes; BFR: 400; DFR: 800.

Review of Dialysis Treatment Details Reports revealed the patient requested early termination of treatment on the following dates:

1/12/2024. Treatment time 155 minutes, short 55 minutes.

1/19/2024. Treatment time 119 minutes, short 91 minutes.

There is no documentation of an Early Termination of Treatment Against Medical Advice form in the MR for the above dates.

MR #4: Admission Date: 3/10/2021. Dialysis order date: 12/19/2023. Frequency: Tuesday, Thursday, and Saturday; Target Weight: 115 Kg; Dialyzer: Revaclear 400; Dialysate: 2 K, 2.5 CA, 35 HCO3, 136 NA; Treatment Duration: 255 minutes; BFR: 550; DFR: 800.

Review of Dialysis Treatment Details Reports revealed the BFR/DFR was not administered at prescribed rates on the following dates:

1/6/2024, during entire treatment BFR was administered at 400 ml/min, and during entire treatment the DFR was administered at 500 ml/min.

1/16/2024, during entire treatment the DFR was administered at 500 ml/min.

1/18/2024, from 11:00 am through 11:53 am, the DFR was administered at 500 ml/min.

There was no documentation in the medical record that the hemodialysis staff had obtained a physician order to allow the BFR/DFR to be administered at a rate different from the prescribed amount for any of the above dates and there was no documentation of a reason why the BFR/DFR was administered at a rate different from the prescribed amount for any of the above dates.

MR #5: Admission Date: 8/6/14. Dialysis order date: 1/18/2024. Frequency: Tuesday, Thursday, and Saturday; Target Weight: 64 Kg; Dialyzer: Optiflux F180NR; Dialysate: 3 K, 2.5 CA, 35 HCO3, 136 NA; Treatment Duration: 180 minutes; BFR: 400; DFR: 600 (Prior order: BFR: 400, DFR: 500).

Review of Dialysis Treatment Details Reports revealed the BFR was not administered at prescribed rates on the following dates:

1/6/2024, during the entire treatment, the BFR was administered at 300 ml/min

There was no documentation in the medical record that the hemodialysis staff had obtained a physician order to allow the BFR to be administered at a rate different from the prescribed amount for the above date and there was no documentation of a reason why the BFR was administered at a rate different from the prescribed amount for the above date.

MR # 6: Admission Date: 11/30/2021. Dialysis order date: 1/3/2024. Frequency: Tuesday, Thursday, and Saturday; Target Weight: 50.5 Kg; Dialyzer: Revaclear 300; Dialysate: 2 K, 2.5 CA, 35 HCO3, 136 NA; Treatment Duration: 210 minutes; BFR: 400; DFR: 500.

Review of Dialysis Treatment Details Reports revealed the patient requested early termination of treatment on the following dates:

1/16/2024. Treatment time 177 minutes, short 33 minutes.

1/18/2024. Treatment time 180 minutes, short 30 minutes.

There is no documentation of an Early Termination of Treatment Against Medical Advice form in the MR for the above date.

An interview with the facility administrator and regional director was conducted on January 24, 2024 at approximately 11:00 am confirmed the above findings.








Plan of Correction:

The Facility Administrator or designee will hold mandatory in-services for all clinical teammates starting on 05/05/24. Surveyor observations were reviewed. Education will include but not be limited to a review of Policy 1-03-08 "Pre- Intra- Post Treatment Data Collection, Monitoring and Nursing Assessment" and Policy 1-01-09 "Prescribed Treatment Time Not Met" with emphasis on but not limited to: A. Pre- Intra- Post Treatment..." 1) Patient identity, prescription and machine settings are verified by teammates prior to initiation of treatment. Prescription components include but are not necessarily limited to ... Blood Flow rate, Dialysate flow rate ... 2) If the dialysis prescription is not being met [including dialysis flow rate or change to/inability to obtain prescribed blood flow rate] the reason will be documented and the licensed nurse informed. 3) All findings, interventions and patient response will be documented in the patient's medical record.
B. Prescribed Treatment Not Met: 1. Completion of Early Termination of Treatment against Medical Advice Form: 1) The Registered Nurse (RN) will verify that a patient signs the "Early Termination of Treatment against Medical Advice" form any time the patient requests to terminate their treatment earlier than the prescribed run time. 2) The RN will obtain the patient's signature on the "Early Termination of Treatment against Medical Advice" form prior to the patient being rinsed back from their treatment. If unable to obtain the patient's signature prior to rinse-back, the RN will obtain the patient's signature on the form prior to the patient's departure from the facility. 3) If a patient refuses to sign the Early Termination of Treatment against Medical Advice form, the RN will document the patient's refusal with the words "patient refused" in the patient signature box along with the date. Under such circumstances, the RN will sign the form and will also obtain a witness' signature on the form. 4) All Early Termination of Treatment against Medical Advice forms will be reviewed for completion and filed each shift by the Charge Nurse. 2. Prescribed Treatment Time Not Met: 1) If shortened/early termination of treatment time exceeds 30 or more minutes, the RN will notify the patient's attending nephrologist to discuss the appropriate intervention (if any), including what additional medical orders may be necessary to address the patient's specific needs. 2) Additionally, if the patient's dialysis treatment is terminated 30 or more minutes prior to the ordered treatment length, the reason must be documented in the patient treatment record at the time the treatment was terminated... 3) The facility's Facility Administrator (FA) will verify that all shortened treatments are recorded and trended, and the FA shall verify that such records are reviewed and discussed at the Facility Health Meetings (FHM), as appropriate.
Verification of attendance at in-service will be evidenced by teammates signature on in-service sheet.
The Facility Administrator or designee completed a one hundred percent (100%) audit of treatment prescriptions orders performed on 1/27/24 and shared results with teammates on 1/29/24. Root cause analysis of the findings was completed with the teammates.
The Facility Administrator or designee will conduct audits to verify complete and accurate documentation and Registered Nurse notification, with appropriate response concerning prescribed blood flow rate, and dialysis flow rate not meeting prescription: on twenty five (25%) of the treatment records daily for two (2) weeks with expected compliance of ninety five percent (95%), then weekly for two (2) weeks with an expected compliance of ninety eight percent (98%).
The Facility Administrator or designee will conduct audits to verify the "Early Termination of Treatment against Medical Advice" form is signed by patient and RN for prescribed treatments not met: on twenty five (25%) of the treatment records daily for two (2) weeks with expected compliance of ninety five percent (95%), then weekly for two (2) weeks with an expected compliance of ninety eight percent (98%).
The Facility Administrator or designee will monitor ongoing compliance for both audits with the monthly ten percent (10%) medical records audit with expected compliance rate of one hundred percent (100%). The Facility Administrator or designee will review the audit results with teammates during homeroom meetings, and with Medical Director during monthly Quality Assessment and Performance Improvement meetings. The Facility Administrator will report progress, as well as any barriers to maintaining compliance. Action plans will be evaluated for effectiveness and new plans developed when needed, until sustained compliance is achieved. Supporting documentation will be included in the meeting minutes. The Facility Administrator is responsible for compliance with this plan of correction.